Late effects of therapy for Hodgkin’s lymphoma
- 240 Downloads
Hodgkin’s lymphoma exemplifies a malignancy in which the benefits and risks of therapy are strikingly obvious: although 70% to 95% of patients survive (depending on disease stage), the late adverse health effects of therapy compromise quality of life and can be fatal. We review the broad range of these potential effects. Although secondary malignancies and cardiovascular disease are the most life-threatening sequelae, pulmonary, endocrine, and reproductive effects can also substantially compromise quality of life. Specific sequelae are not distributed evenly among survivors but depend on characteristics of the patient and treatment. Recent risk-adapted treatment protocols have eliminated or reduced the use of therapies most associated with adverse effects, such as alkylating agents, anthracyclines, and radiotherapy. Early studies suggest that these strategies reduce the frequency and severity of adverse effects, but additional follow-up of patients is necessary to confirm improved outcomes. Recognition of adverse effects has also led to recommendations for screening.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Ries LAG, Eisner MP, Kosary C, et al.: SEER Cancer Statistics Review, 1973–2001. Bethesda, MD: National Cancer Institute; 2004.Google Scholar
- 7.Dores GM, Metayer C, Curtis RE, et al.: Second malignant neoplasms among long-term survivors of Hodgkin’s disease: a population-based evaluation over 25 years. J Clin Oncol 2002, 3484–3494.Google Scholar
- 35.Friedman DL, Constine LS: Late effects of treatment for Hodgkin lymphoma. J Natl Comp Cancer Netw 2006, 4:249–257.Google Scholar
- 42.Behringer K, Breuer K, Reineke T, et al.: Secondary amenorrhea after Hodgkin’s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin’s Lymphoma Study Group. J Clin Oncol 2005, 23:7555–7564.PubMedCrossRefGoogle Scholar
- 50.Children’s Oncology Group: Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers (Ver. 2.0, 2006). http://www.survivorshipguidelines.org/. Accessed March 2007.
- 52.Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol In Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497.CrossRefGoogle Scholar